Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cytotherapy|February 4, 2012
Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serumKaren Bieback, Andrea Hecker, Tanja Schlechter, et al.
Plos One|May 7, 2014
The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cellsTorben Redmer, Yvonne Welte, Diana Behrens, et al.
Acta Neuropathologica|February 22, 2024
MET receptor serves as a promising target in melanoma brain metastasesTorben Redmer, Elisa Schumann, Kristin Peters, et al.
Journal of Animal Science and Biotechnology|March 1, 2026
Transcriptional adaptation of rumen papillae to high-grain diet reveals distinct temporal phases and SARA susceptibility signaturesKalina Duszka, Ezequias Castillo-Lopez, Thomas Hartinger, et al.
Nature Communications|November 26, 2022
Decoding molecular programs in melanoma brain metastasesJosefine Radke, Elisa Schumann, Julia Onken, et al.
The Journal of Investigative Dermatology|September 26, 2024
Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative DiseasesIrene Soler-Sáez, Alcida Karz, Marta R Hidalgo, et al.
Molecular Cancer|May 4, 2025
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancerEmine Atas, Kerstin Berchtold, Michaela Schlederer, et al.
Cancers|July 27, 2022
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEALJörg Kumbrink, Lisa Bohlmann, Soulafa Mamlouk, et al.
Nature Communications|January 26, 2017
DNA copy number changes define spatial patterns of heterogeneity in colorectal cancerSoulafa Mamlouk, Liam Harold Childs, Daniela Aust, et al.
Molecular Cancer|November 1, 2024
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.
Pageof 3